Global Infection Prevention & Control Market Size By Type (Enteral Feeding Pumps, Enteral Feeding Tubes), By Application (Oncology, Gastroenterology), By Region, And Segment Forecasts, 2023 to 2032

The Global Infection Prevention & Control Market was valued at USD 112.5 billion in 2023 and is expected to surpass USD 178.9 billion by 2031, growing at a CAGR of 6.1% during the forecast period of 2023-2031. The market is driven by the rising prevalence of hospital-acquired infections (HAIs), the increasing emphasis on hygiene and sanitation, and advancements in sterilization and disinfection technologies. The growing aging population, rising surgical procedures, and expansion of healthcare infrastructure are further fueling the demand for infection prevention and control solutions.

Market Drivers

Increasing Prevalence of Hospital-Acquired Infections (HAIs)

HAIs pose a significant health risk to patients and healthcare providers worldwide. The rising incidence of infections such as bloodstream infections, surgical site infections, and ventilator-associated pneumonia is driving the demand for infection prevention measures, including sterilization equipment, disinfectants, and protective barriers.

Stringent Regulatory Guidelines and Compliance

Regulatory authorities such as the Centers for Disease Control and Prevention (CDC), the World Health Organization (WHO), and the U.S. Food and Drug Administration (FDA) are enforcing strict infection control guidelines. These regulations mandate hospitals, laboratories, and pharmaceutical companies to adhere to stringent disinfection and sterilization protocols.

Technological Advancements in Infection Prevention Solutions

The market is witnessing innovations in disinfection and sterilization methods, including UV-C disinfection, antimicrobial coatings, and advanced sterilization technologies. These solutions are reducing the risk of contamination and enhancing patient safety, thereby driving market growth.

Market Restraints

High Costs Associated with Infection Control Products

The adoption of advanced sterilization and disinfection equipment involves high capital expenditure, which can be a barrier for small healthcare facilities and clinics, particularly in developing regions. The cost of compliance with infection control regulations also adds to the financial burden.

Limited Awareness and Training in Emerging Economies

Despite the rising threat of infections, the awareness regarding infection control measures remains low in certain developing regions. A lack of proper training among healthcare staff regarding the use of personal protective equipment (PPE) and sterilization techniques can hinder market growth.

Market Opportunity

Growing Demand in Emerging Markets

Developing regions such as Asia-Pacific, Latin America, and the Middle East are witnessing rapid expansion in healthcare infrastructure. The increasing investment in hospitals, clinics, and diagnostic laboratories is creating a high demand for infection control products and services.

Adoption of Eco-Friendly Disinfection Solutions

With growing concerns over antimicrobial resistance (AMR) and chemical toxicity, manufacturers are investing in green disinfectants, biodegradable PPE, and sustainable sterilization solutions. This shift towards environmentally friendly infection control products presents a significant growth opportunity.

Rising Telemedicine and Home Healthcare Services

With the rise in home-based patient care and telemedicine services, there is a growing need for infection control measures beyond hospitals. Products such as hand sanitizers, surface disinfectants, and antimicrobial coatings are witnessing increased demand in household settings.

Market by System Type Insights

Sterilization Products Dominated the Market in 2023

Among various infection control solutions, sterilization products held the largest market share in 2023. This includes autoclaves, low-temperature sterilizers, and sterilization indicators, which are widely used in hospitals, laboratories, and pharmaceutical settings to eliminate pathogens.

Protective Barriers Segment to Witness Strong Growth

The demand for personal protective equipment (PPE), gloves, masks, gowns, and drapes is growing significantly, driven by the ongoing threat of infectious diseases, including COVID-19 and influenza outbreaks.

Market by End-Use Insights

Hospitals & Clinics Accounted for the Largest Market Share

Hospitals remain the largest consumer of infection prevention products, accounting for over 45% of the market share in 2023. The high volume of patient admissions, surgical procedures, and risk of infections drive the demand for disinfection and sterilization solutions.

Pharmaceutical & Biotechnology Companies to Drive Future Demand

The pharmaceutical industry relies on stringent sterilization techniques to maintain aseptic manufacturing environments. The expansion of drug development activities and vaccine production is expected to fuel market growth in this segment.

Market by Regional Insights

North America Dominated the Market

North America accounted for the largest share in 2023, driven by strict regulatory guidelines, high healthcare spending, and the presence of major infection control companies. The United States leads the region, with robust investments in hospital infrastructure and research.

Asia-Pacific Expected to Witness the Fastest Growth

The Asia-Pacific region is expected to experience the highest CAGR during the forecast period, owing to rapid urbanization, rising healthcare awareness, and increasing government initiatives for infection control in countries such as China, India, and Japan.

Competitive Scenario

Key players operating in the Global Infection Prevention & Control Market include:

3M Company

Ecolab Inc.

Steris Corporation

Getinge AB

Cantel Medical Corporation

Metrex Research, LLC

Advanced Sterilization Products (ASP)

Belimed AG

Diversey Holdings, Ltd.

PAUL HARTMANN AG

These companies are focusing on strategic acquisitions, product innovations, and partnerships to strengthen their market position. Recent developments include:

In 2023, Steris Corporation launched an advanced low-temperature hydrogen peroxide sterilizer to enhance infection control in surgical settings.

Ecolab introduced an AI-powered infection control system in 2022 to track and prevent hospital-acquired infections in real-time.

3M expanded its production of antimicrobial coatings in 2024 to meet the growing demand for long-lasting surface disinfection solutions.

Scope of Work – Global Infection Prevention & Control Market

Key Market Developments

June 2023: Steris Corporation introduced a next-generation automated disinfection system designed for intensive care units (ICUs).

March 2023: Ecolab partnered with a global healthcare provider to develop a cloud-based infection monitoring platform.

January 2023: 3M announced an expansion in antimicrobial film technology, aimed at reducing cross-contamination risks in hospitals.

FAQs

1. What is the current market size of the Global Infection Prevention & Control Market?

The market was valued at USD 112.5 billion in 2023 and is expected to grow steadily.

2. What is the major growth driver of the Global Infection Prevention & Control Market?

The market is primarily driven by the rising prevalence of hospital-acquired infections (HAIs) and stringent regulatory compliance.

3. Which region dominates the Global Infection Prevention & Control Market?

North America accounted for the largest market share in 2023 due to high healthcare spending and strong regulatory frameworks.

4. Which segment accounted for the largest market share in the Global Infection Prevention & Control Market?

The Sterilization Products segment dominated the market in 2023, owing to its critical role in infection control.

5. Who are the key players in the Global Infection Prevention & Control Market?

Major players include 3M Company, Ecolab Inc., Steris Corporation, Getinge AB, and Cantel Medical Corporation, among others.

This comprehensive report provides insights into market trends, growth opportunities, key developments, and regional dynamics within the Global Infection Prevention & Control Market.